Nasdaq stocks posting largest percentage increases
AP - Fri Aug 08, 5:06PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
Relypsa to Present at Wedbush PacGrow Lifesciences 2014 Conference
GlobeNewswire - Thu Aug 07, 3:44PM CDT
Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that John Orwin, Chief Executive Officer, will present a corporate overview at the Wedbush PacGrow Lifesciences Conference on August 13, 2014 at 9:10 a.m. ET.
Will Relypsa (RLYP) Continue to Surge Higher? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jul 07, 7:40AM CDT
Will Relypsa (RLYP) Continue to Surge Higher?
Relypsa Adds Industry Veterans Daniel K. Spiegelman and kenneth J. Hillan to Its Board of Directors
GlobeNewswire - Thu Jun 19, 3:05PM CDT
Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced the election of Daniel K. Spiegelman, executive vice president and chief financial officer of BioMarin Pharmaceutical Inc., and Kenneth J. Hillan, president and chief executive officer of Achaogen, Inc., to its board of directors following the company's annual meeting of stockholders held earlier today. Mr. Spiegelman and Dr. Hillan are well established biopharmaceutical executives with expertise in managing public companies through research and development to international commercial operations.
Weakness Seen in Relypsa (RLYP): Stock Falls 7.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jun 11, 7:58AM CDT
Relypsa (RLYP) fell over 7% in the last trading session amid huge volumes, continuing its recent volatile trend as it is currently trading within the volatile price range of last one month.
Relypsa Secures Loan Facility of Up to $35 Million
GlobeNewswire - Mon Jun 02, 8:33AM CDT
Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced it has secured a loan facility of up to $35 million with Oxford Finance LLC ("Oxford"
Relypsa Names Sylvia R. Wheeler V.P. Investor Relations and Corporate Affairs
GlobeNewswire - Wed Apr 02, 8:43AM CDT
Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced the appointment of Sylvia R. Wheeler to the position of Vice President, Investor Relations and Corporate Affairs. Ms. Wheeler, a veteran biopharmaceutical executive, joins Relypsa with over 20 years of experience in investor relations and corporate communications. In her new role, Ms. Wheeler will be a member of the leadership team and will report to John Orwin, President and Chief Executive Officer of Relypsa.
Weakness Seen in Relypsa (RLYP): Stock Plunges 19.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 27, 7:42AM CDT
Relypsa (RLYP) fell over 19% in the last trading session amid high volumes, breaking its recent volatile trend as it is currently trading below the volatile price range of last one month.
Relypsa (RLYP) in Focus: Stock Adds 12.4% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 26, 8:46AM CDT
Relypsa was a big mover last session, with shares rising over 12% on the day.
Rev Shark: A Messy Day of Action
at The Street - Wed Mar 19, 3:31PM CDT
A few minor changes to Fed policy were enough to spook the market.
Narrower-Than-Expected Loss at Relypsa - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 18, 8:20AM CDT
Relypsa reported a loss of 68 cents per share narrower than the Zacks Consensus Estimate of a loss of 74 cents.
Relypsa Announces Fourth Quarter and Full Year 2013 Financial Results
GlobeNewswire - Mon Mar 17, 3:26PM CDT
Relypsa, Inc. (Nasdaq: RLYP), a biopharmaceutical company, today reported financial results for the fourth quarter and year ended December 31, 2013.
Relypsa to Present at Two Upcoming Investor Conferences in March
GlobeNewswire - Wed Feb 26, 8:22AM CST
Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that John Orwin, Chief Executive Officer, will present a corporate overview of the company at the Cowen & Co. 34th Annual Health Care Conference in Boston, MA on March 4 at 10:40 am ET and at the 26th Annual ROTH Conference in Dana Point, CA on March 10 at 5:00 pm PT.